Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 2 · 50%High 0 · 0%

Total cardiovascular disease

Beta‐blockers probably leads to higher total cardiovascular disease compared with calcium‐channel blockers (moderate certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 1.18 [1.08, 1.29]
2 studies · 19915 participants
Moderate

Total cardiovascular disease

Beta‐blockers showed no clear difference in total cardiovascular disease compared with renin‐angiotensin system inhibitors (low certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 1 [0.72, 1.38]
3 studies · 10828 participants
Low

Total cardiovascular disease

Beta‐blockers may leads to lower total cardiovascular disease compared with placebo (low certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 0.88 [0.79, 0.97]
4 studies · 23613 participants
Low

Total cardiovascular disease

Beta‐blockers showed no clear difference in total cardiovascular disease compared with diuretics (moderate certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 1.13 [0.99, 1.28]
4 studies · 18135 participants
Moderate